Ledger.Open graph →

SEC Form D · Amendment · filed June 14, 2011

Revance Therapeutics, Inc

Offering

$45.0M

Sold

$45.0M

Exemption

—

Industry

Pharmaceuticals

Location

NEWARK, CA

Type

—

People & firms on this filing (14)

L. D. Browne · Newark, CAExec · Director Frank Kung · Newark, CADirector Jim Glasheen · Newark, CADirector Phyllis Gardner · Newark, CADirector Ron Eastman · Newark, CADirector Robert Byrnes · Newark, CADirector Vicente Trelles · Newark, CADirector Joel R. Beaudin · North River, NYExec · Director Dan Beecroft · Boca Raton, FLDirector Blake Beecroft · Boca Raton, FLDirector Toney Jennings · Austin, TXDirector Daniel M. Teal · Austin, TXDirector Richard Teal · Austin, TXDirector Gregory J. Petro · Pittsburgh, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗